PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10138610

Collaborative practice.

L DeAngelo
View original source ↗Export metadata ↓

Abstract

Linda DeAngelo, RNC, M.S.A., M.B.A., of the Carle Clinic, relates how mid-level providers and physicians collaborate to offer cost-effective, quality care while returning a high level of patient satisfaction. She highlights the history of mid-level providers at Carle and describes the efficiencies and indirect benefits that their inclusion in the care team permits.

Explore related subjects

Cost-Benefit AnalysisEfficiency, OrganizationalGroup PracticeIllinoisInterprofessional RelationsNurse CliniciansNurse MidwivesNurse PractitionersPatient Care TeamPersonnel Staffing and SchedulingPhysician AssistantsPhysiciansJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L DeAngelo. Collaborative practice.. https://pubmed.ncbi.nlm.nih.gov/10138610/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2000

Active versus passive immunization against hepatitis A in the Israel defence forces: a cost-benefit analysis.

We compared cost-benefit and cost-effectiveness analyses of hepatitis A prevention with immune serum globulin (ISG) vs inactivated hepatitis A vaccine (iHAV) in the Israel Defence Forces. Personnel were grouped according to conditions and duration of service and analyses were performed based on maximum and minimum hepatitis A projected incidences for each group. For standing army soldiers in field units, iHAV is economically superior compared with ISG. For the five other groups studied, the reverse is true. Expected increases in production costs of ISG and expected decreases in costs of iHAV are likely to make iHAV more economical in the future.

Cost-Benefit Analysis↗
PubMed2000

[Partial re-screening of all negative smears. A method of quality control of pathology department concerning smear screening against cervix cancer].

Partial rescreening of all negative smears is recommended as the most cost-effective method of internal quality control. The method was tested by eight cytotechnologists and the average diagnostic sensitivity, assessed upon their answering of 200 test-smears (150 negative and 50 positive) was 80%, while specificity vas calculated to 95%. Partial rescreening has here-upon been used in daily routine. After one year 21,000 smears have been re-screened. Twenty-nine cases of false negatives, 16 with atypia, eight with koilocytosis, and five cases with dysplasia have been detected, which corresponds to an overall false negative rate on 3%. In five of the 29 false negative cases with dysplasia histological follow-up has shown three cases of CIN III (two carcinoma in situ, one severe dysplasia), one case with CIN II (moderate dysplasia) and one case with CIN I (mild dysplasia). Conclusively, partial rescreening of all negative smears implies an improved quality with reduction of the number of false negative specimens.

Cost-Benefit Analysis↗